|
EP2195321B1
(en)
|
2007-04-12 |
2016-10-19 |
Pfizer Inc. |
3-amido-pyrrolo[3,4-c]pyrazole-5(1h, 4h,6h) carbaldehyde derivatives as inhibitors of protein kinase c
|
|
WO2009144554A1
(en)
|
2008-05-28 |
2009-12-03 |
Pfizer, Inc. |
Pyrazolospiroketone acetyl-c0a carboxylase inhibitors
|
|
EP2485727A4
(en)
*
|
2009-10-06 |
2013-05-01 |
Afraxis Inc |
PYRROLOPYRAZOLE FOR THE TREATMENT OF CNS DISEASES
|
|
PT2499139E
(pt)
*
|
2009-11-10 |
2014-02-10 |
Pfizer |
Inibidores de n1-pirazolospirocetona acetil-coa carboxilase
|
|
WO2011090738A2
(en)
|
2009-12-29 |
2011-07-28 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
|
WO2011107494A1
(de)
|
2010-03-03 |
2011-09-09 |
Sanofi |
Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
WO2011157827A1
(de)
|
2010-06-18 |
2011-12-22 |
Sanofi |
Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
TW201215387A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Aventis |
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
|
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
|
SI2621493T1
(sl)
|
2010-09-30 |
2016-10-28 |
Pfizer Inc. |
Zaviralci N1-pirazolospiroketon acetil-CoA-karboksilaze
|
|
MX2013004733A
(es)
|
2010-10-29 |
2013-07-02 |
Pfizer |
Inhibidores de n1/n2-lactama acetil-coa carboxilasa.
|
|
US8841463B2
(en)
|
2011-02-11 |
2014-09-23 |
Glaxosmithkline Intellectual Property Development Limited |
Cathepsin C inhibitors
|
|
HRP20151397T1
(hr)
|
2011-04-22 |
2016-01-15 |
Pfizer Inc. |
DERIVATI PIRAZOLOSPIROKETONA, NAMIJENJENI UPOTREBI KAO INHIBITORI ACETIL-CoA-KARBOKSILAZE
|
|
WO2013037390A1
(en)
|
2011-09-12 |
2013-03-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
EP2567959B1
(en)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
US8846712B2
(en)
|
2011-09-12 |
2014-09-30 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
JP6165733B2
(ja)
*
|
2011-09-16 |
2017-07-19 |
ノバルティス アーゲー |
Ｎ−置換ヘテロシクリルカルボキサミド類
|
|
WO2013045413A1
(en)
|
2011-09-27 |
2013-04-04 |
Sanofi |
6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
AU2012340200B2
(en)
|
2011-11-17 |
2017-10-12 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of c-Jun-N-Terminal Kinase (JNK)
|
|
EP2847191B1
(en)
|
2012-05-09 |
2016-06-15 |
Sanofi |
Substituted 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors
|
|
WO2014063061A1
(en)
|
2012-10-19 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
|
US10154988B2
(en)
|
2012-11-14 |
2018-12-18 |
The Johns Hopkins University |
Methods and compositions for treating schizophrenia
|
|
CA2927920A1
(en)
|
2013-10-18 |
2015-04-23 |
Dana-Farber Cancer Institute, Inc. |
Polycyclic inhibitors of cyclin-dependent kinase 7 (cdk7)
|
|
EP3057955B1
(en)
|
2013-10-18 |
2018-04-11 |
Syros Pharmaceuticals, Inc. |
Heteroaromatic compounds useful for the treatment of prolferative diseases
|
|
JP2017516853A
(ja)
|
2014-05-23 |
2017-06-22 |
ミングサイト ファーマシューティカルズ，インク． |
自己免疫性疾患の処置
|
|
EP3214086B1
(en)
|
2014-10-31 |
2021-09-22 |
Ube Industries, Ltd. |
Substituted dihydropyrrolopyrazole compound
|
|
US20170246166A1
(en)
*
|
2014-11-21 |
2017-08-31 |
Eli Lilly And Company |
1,2-benzothiazole compounds for the treatment of kidney disorders
|
|
AU2015371251B2
(en)
|
2014-12-23 |
2020-06-11 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (CDK7)
|
|
US10550121B2
(en)
|
2015-03-27 |
2020-02-04 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
|
WO2016204153A1
(ja)
*
|
2015-06-15 |
2016-12-22 |
宇部興産株式会社 |
置換ジヒドロピロロピラゾール誘導体
|
|
WO2017044858A2
(en)
|
2015-09-09 |
2017-03-16 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
|
AU2016355303B2
(en)
|
2015-11-20 |
2021-10-07 |
Mingsight Pharmaceuticals, Inc. |
Treatment of autoimmune disease
|
|
US11154555B2
(en)
|
2016-07-14 |
2021-10-26 |
Mingsight Pharmaceuticals, Inc. |
Treatment of cancer
|
|
CA3099763A1
(en)
|
2018-06-25 |
2020-01-02 |
Dana-Farber Cancer Institute, Inc. |
Taire family kinase inhibitors and uses thereof
|
|
WO2020100944A1
(ja)
|
2018-11-14 |
2020-05-22 |
宇部興産株式会社 |
ジヒドロピロロピラゾール誘導体
|
|
CA3124422A1
(en)
|
2018-12-28 |
2020-07-02 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 and uses thereof
|
|
CN119684220A
(zh)
*
|
2024-12-13 |
2025-03-25 |
江苏宝众宝达药业股份有限公司 |
一种(2r,5r)-1,2,5-三甲基哌嗪的制备方法
|